Hadron Therapy Symposium: status and perspectives, plans for next generation facilities

June 12, 2024

Registration is open for Hadron Therapy Symposium: status and perspectives, plans for next generation facilities, to be held in Thessaloniki from October 18 to 21, 2024 in hybrid mode and free of charge.

This four-days international event will present an Overeview of the Status and Perspectives of Hadron Therapy and will include a specialised 2-days workshop; a specialized 1-day course on Treatement Planning; students sessions and networking events for newcomers in Heavy Ion Therapy Research with a focus on clinical aspects.

The lectures will be delivered by over 10 world-leading experts in the field. They will cover the basic principles of hadron therapy and radiobiology, experiences of the European running hadron therapy centres and their future plans, present and future clinical trials, and will include specific indications for hadron therapy such as head and neck, sarcoma and others. Dedicated sessions will address pediatrics as well as emerging methods, such as combinations of hadron therapy with immunotherapy and FLASH therapy, highlighting also unfolding reserach avenues and the related necessary technical advancements.

The 1-day course dedicated to Treatement Planning is inspired by the  “train-the-trainer” hands-on session of the very popular May 2021 HITRIplus Masterclass school. This is based on the professional, open-source, research toolkit matRad, tailored to researcher and education requirements in treatment planning.

The Hadron Therapy Symposium is primarily intended to clinicians of all levels in radiotherapy and particle therapy as well as for medical students specializing or considering specializing in oncology. The ultimate goal is to address and prepare motivated oncologists, as well as early-stage researchers and students who show strong promise and interest in becoming part of the heavy ion therapy research community and who may then optimally exploit and access Europe’s heavy ion therapy research infrastructures.




Latest news